XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid in Capital
Retained Earnings
Unallocated Common Stock of ESOP
Accumulated Other Comprehensive Income
Total
Balance at beginning of period at Dec. 31, 2023 $ 260 $ 113,432 $ 180,156 $ (10,233) $ 181 $ 283,796
Balance at beginning of period (in shares) at Dec. 31, 2023 25,977,679          
Increase (Decrease) in Shareholder's Equity            
Net income     4,719     4,719
Other comprehensive income         319 319
ESOP shares committed to be released (in shares)   (49)   171   122
Balance at end of period at Mar. 31, 2024 $ 260 113,383 184,875 (10,062) 500 288,956
Balance at end of period (in shares) at Mar. 31, 2024 25,977,679          
Balance at beginning of period at Dec. 31, 2024 $ 260 114,113 194,188 (9,551) 5,543 $ 304,553
Balance at beginning of period (in shares) at Dec. 31, 2024 25,978,904         25,978,904
Increase (Decrease) in Shareholder's Equity            
Net income     5,763     $ 5,763
Other comprehensive income         1,458 1,458
ESOP shares committed to be released (in shares)   (23)   171   148
Stock-based compensation expense   351       351
Restricted stock awards granted (in shares) 5,000          
Repurchases of common stock $ (2)   (1,570)     (1,572)
Repurchases of common stock (in shares) (130,813)          
Balance at end of period at Mar. 31, 2025 $ 258 $ 114,441 $ 198,381 $ (9,380) $ 7,001 $ 310,701
Balance at end of period (in shares) at Mar. 31, 2025 25,853,091         25,853,091